Device Trial Radar · NCT06923774
European Real-World Registry for Use of the Ion Endoluminal System
Last checked: Nov 21, 2026Latest source record: Oct 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,200
Planned (sponsor's estimate)
Start
Sep 9, 2025
Primary completion
Oct 2029
Study completion Oct 2029
Sponsor
- Lead sponsor
- Intuitive SurgicalPublic (ISRG)
- Sponsor type
- Industry
- First posted
- Apr 11, 2025
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to collect collect real-world data for the Ion endoluminal system.
Conditions
- Pulmonary Nodule
- Lung Cancer
Interventions
Ion endoluminal systemDevice
Lung nodule biopsy and/or localization procedure using the Ion endoluminal system per sites' standard of care
Primary outcomes
What the sponsor says the trial is designed to measure.
- Diagnostic YieldTime frame: Intra-procedure through 24 month post-procedure
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
CHU de Brest, Hôpital de La Cavale Blanche
Brest, France · Not yet recruiting
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.